Literature DB >> 16543252

The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.

Jozef Bartunek1, Stephanie Dimmeler, Helmut Drexler, Francisco Fernández-Avilés, Manuel Galinanes, Stefan Janssens, John Martin, Anthony Mathur, Phillipe Menasche, Sylvia Priori, Bodo Strauer, Michal Tendera, William Wijns, Andreas Zeiher.   

Abstract

A task force has been established by the European Society of Cardiology to investigate the role of progenitor/stem cell therapy in the treatment of cardiovascular disease. This article is the consensus of this group, of what clinical studies are needed in this field, and the challenges to be addressed in the translation of progenitor/stem cell biology to repair of the heart.

Entities:  

Mesh：

Year:  2006        PMID： 16543252     DOI： 10.1093/eurheartj/ehi793

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  33 in total

1.  Panoramic view of the Fifth International Symposium on Stem Cell Therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain).

Authors:  Adolfo Villa; Ricardo Sanz; M Eugenia Fernandez; Jaime Elizaga; Indrig Ludwig; Pedro L Sanchez; Francisco Fernandez-Aviles
Journal:  J Cardiovasc Transl Res       Date:  2008-09-19       Impact factor: 4.132

2.  Stem cell therapy trials: a call for standardization.

Authors:  Leslie W Miller
Journal:  J Cardiovasc Transl Res       Date:  2008-07-22       Impact factor: 4.132

Review 3.  Heart repair and stem cells.

Authors:  Linda W van Laake; Rutger Hassink; Pieter A Doevendans; Christine Mummery
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

4.  Repairing damaged myocardium: evaluating cells used for cardiac regeneration.

Authors:  Adam J T Schuldt; Michael R Rosen; Glenn R Gaudette; Ira S Cohen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

Review 5.  [Stem cells--cloning, plasticity, bioethic].

Authors:  Pamina Pflegerl; Thomas Keller; Brigitte Hantusch; Thomas Sören Hoffmann; Lukas Kenner
Journal:  Wien Med Wochenschr       Date:  2008

Review 6.  Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.

Authors:  Jörn Tongers; Douglas W Losordo; Ulf Landmesser
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Authors:  Virginie F Forest; Ashok M Tirouvanziam; Christian Perigaud; Sarah Fernandes; Marion S Fusellier; Jean-Claude Desfontis; Claire S Toquet; Marie-Françoise M Heymann; Dominique P Crochet; Patricia F Lemarchand
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

9.  Phases I-III Clinical Trials Using Adult Stem Cells.

Authors:  Ricardo Sanz-Ruiz; Enrique Gutiérrez Ibañes; Adolfo Villa Arranz; María Eugenia Fernández Santos; Pedro L Sánchez Fernández; Francisco Fernández-Avilés
Journal:  Stem Cells Int       Date:  2010-11-04       Impact factor: 5.443

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.